Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
198 INR | +1.51% | -5.96% | -13.16% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 130.4 | 109.1 | 140.6 | 207.2 | 678.8 | 863.9 |
Enterprise Value (EV) 1 | 163.3 | 164.2 | 191 | 254.9 | 712.2 | 868.5 |
P/E ratio | 8.66 x | 5.36 x | 3.48 x | 3.77 x | 15.8 x | 12.5 x |
Yield | 0.78% | 1.13% | 0.87% | 0.59% | 0.18% | 0.14% |
Capitalization / Revenue | 0.48 x | 0.37 x | 0.28 x | 0.28 x | 0.93 x | 1.1 x |
EV / Revenue | 0.6 x | 0.55 x | 0.38 x | 0.35 x | 0.97 x | 1.11 x |
EV / EBITDA | 4.68 x | 3.93 x | 3.43 x | 3.1 x | 11.9 x | 9.95 x |
EV / FCF | 18.1 x | -9 x | 5.18 x | 6.38 x | -348 x | -45.8 x |
FCF Yield | 5.52% | -11.1% | 19.3% | 15.7% | -0.29% | -2.18% |
Price to Book | 1.29 x | 0.9 x | 0.88 x | 0.97 x | 2.65 x | 2.67 x |
Nbr of stocks (in thousands) | 4,094 | 4,094 | 4,094 | 4,094 | 4,094 | 4,094 |
Reference price 2 | 31.85 | 26.65 | 34.35 | 50.60 | 165.8 | 211.0 |
Announcement Date | 04/09/18 | 02/09/19 | 04/09/20 | 03/09/21 | 04/09/22 | 25/08/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 273.1 | 296.7 | 504.5 | 735.9 | 732 | 783.1 |
EBITDA 1 | 34.86 | 41.81 | 55.72 | 82.3 | 59.79 | 87.29 |
EBIT 1 | 26 | 32.55 | 45.4 | 72.97 | 48.22 | 74.77 |
Operating Margin | 9.52% | 10.97% | 9% | 9.92% | 6.59% | 9.55% |
Earnings before Tax (EBT) 1 | 20.97 | 28.24 | 56.83 | 73.91 | 59.72 | 92.34 |
Net income 1 | 15.05 | 20.36 | 40.39 | 54.99 | 43.02 | 69.13 |
Net margin | 5.51% | 6.86% | 8.01% | 7.47% | 5.88% | 8.83% |
EPS 2 | 3.676 | 4.970 | 9.865 | 13.43 | 10.51 | 16.89 |
Free Cash Flow 1 | 9.003 | -18.24 | 36.9 | 39.97 | -2.047 | -18.96 |
FCF margin | 3.3% | -6.15% | 7.31% | 5.43% | -0.28% | -2.42% |
FCF Conversion (EBITDA) | 25.83% | - | 66.22% | 48.56% | - | - |
FCF Conversion (Net income) | 59.83% | - | 91.36% | 72.68% | - | - |
Dividend per Share 2 | 0.2500 | 0.3000 | 0.3000 | 0.3000 | 0.3000 | 0.3000 |
Announcement Date | 04/09/18 | 02/09/19 | 04/09/20 | 03/09/21 | 04/09/22 | 25/08/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 32.9 | 55.1 | 50.4 | 47.7 | 33.4 | 4.63 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.9425 x | 1.318 x | 0.9039 x | 0.5798 x | 0.5581 x | 0.053 x |
Free Cash Flow 1 | 9 | -18.2 | 36.9 | 40 | -2.05 | -19 |
ROE (net income / shareholders' equity) | 16% | 18.3% | 28.7% | 29.4% | 18.3% | 23.9% |
ROA (Net income/ Total Assets) | 8.2% | 8.51% | 9.1% | 10.8% | 5.79% | 9.68% |
Assets 1 | 183.6 | 239.2 | 443.8 | 508.2 | 742.7 | 714.4 |
Book Value Per Share 2 | 24.60 | 29.60 | 39.10 | 52.30 | 62.50 | 79.00 |
Cash Flow per Share 2 | 2.420 | 2.670 | 6.540 | 2.040 | 3.360 | 3.560 |
Capex 1 | 30.6 | 14 | 6.02 | 7.62 | 32.5 | 11.3 |
Capex / Sales | 11.22% | 4.72% | 1.19% | 1.04% | 4.43% | 1.44% |
Announcement Date | 04/09/18 | 02/09/19 | 04/09/20 | 03/09/21 | 04/09/22 | 25/08/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.16% | 9.71M | |
+2.46% | 102B | |
-8.98% | 60.79B | |
+74.76% | 48.86B | |
+13.97% | 37.96B | |
+4.56% | 32.37B | |
+14.72% | 20.64B | |
+11.17% | 16.58B | |
+8.81% | 13.93B | |
-3.19% | 13.25B |
- Stock Market
- Equities
- PROLIFE Stock
- Financials Prolife Industries Limited